Patent-pending UVAP7 cells, an exclusive cellular model that simulates "double aging: natural aging + photo-aging".

It modulates the activation of multiple cutaneous receptors to inhibit the production and signaling induction of glutamate, thereby alleviating cutaneous discomfort.

It exerts anti-spot and skin whitening efficacy for the skin through two mechanisms: inhibiting melanin synthesis and blocking the protease-activated receptor 2 (PAR2) mediated melanin transport in keratinocytes.

Anglysin IB could improve skin yellowing, enhance skin brightness, and delay skin aging by inhibiting protein glycation and carbonylation.

Erythcalm SC could effectively inhibit the activation of ADRB2, HRH1, TRPV1 and EDNRA, thereby reducing the release of the vasodilator CGRP, and relieving skin redness caused by different stimuli.

Gmoist CS can accurately act on the intelligent moisturizing pathway of the skin, leading to a strong moisturizing effect that help the skin deal with various environmental changes.